nodes	percent_of_prediction	percent_of_DWPC	metapath
Amobarbital—GRIK2—nerve—skin cancer	0.0352	0.135	CbGeAlD
Amobarbital—CHRNA7—skin epidermis—skin cancer	0.0336	0.129	CbGeAlD
Amobarbital—CHRNA4—nerve—skin cancer	0.0283	0.108	CbGeAlD
Amobarbital—Dermatitis exfoliative—Imiquimod—skin cancer	0.0226	0.0306	CcSEcCtD
Amobarbital—Liver injury—Temozolomide—skin cancer	0.0209	0.0283	CcSEcCtD
Amobarbital—GABRA3—neck—skin cancer	0.0191	0.0732	CbGeAlD
Amobarbital—Respiratory failure—Temozolomide—skin cancer	0.0179	0.0242	CcSEcCtD
Amobarbital—Constipation—Vismodegib—skin cancer	0.017	0.023	CcSEcCtD
Amobarbital—Depressed level of consciousness—Temozolomide—skin cancer	0.017	0.023	CcSEcCtD
Amobarbital—CHRNA7—neck—skin cancer	0.0161	0.0617	CbGeAlD
Amobarbital—Mental disability—Temozolomide—skin cancer	0.0153	0.0207	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Temozolomide—skin cancer	0.0135	0.0183	CcSEcCtD
Amobarbital—Vomiting—Vismodegib—skin cancer	0.0126	0.0171	CcSEcCtD
Amobarbital—Rash—Vismodegib—skin cancer	0.0125	0.017	CcSEcCtD
Amobarbital—Dermatitis—Vismodegib—skin cancer	0.0125	0.0169	CcSEcCtD
Amobarbital—Ataxia—Temozolomide—skin cancer	0.012	0.0163	CcSEcCtD
Amobarbital—Respiratory failure—Docetaxel—skin cancer	0.0119	0.0161	CcSEcCtD
Amobarbital—Nausea—Vismodegib—skin cancer	0.0118	0.016	CcSEcCtD
Amobarbital—Agitation—Imiquimod—skin cancer	0.0118	0.016	CcSEcCtD
Amobarbital—Angioedema—Imiquimod—skin cancer	0.0117	0.0159	CcSEcCtD
Amobarbital—Hepatocellular injury—Docetaxel—skin cancer	0.0117	0.0158	CcSEcCtD
Amobarbital—Injection site reaction—Docetaxel—skin cancer	0.0116	0.0157	CcSEcCtD
Amobarbital—Syncope—Imiquimod—skin cancer	0.0115	0.0156	CcSEcCtD
Amobarbital—Hypotension—Vemurafenib—skin cancer	0.0115	0.0155	CcSEcCtD
Amobarbital—Loss of consciousness—Imiquimod—skin cancer	0.0113	0.0153	CcSEcCtD
Amobarbital—Ataxia—Fluorouracil—skin cancer	0.0111	0.015	CcSEcCtD
Amobarbital—GABRA4—mammalian vulva—skin cancer	0.011	0.0421	CbGeAlD
Amobarbital—Anxiety—Imiquimod—skin cancer	0.0109	0.0147	CcSEcCtD
Amobarbital—Constipation—Vemurafenib—skin cancer	0.0105	0.0142	CcSEcCtD
Amobarbital—CHRNA7—skin of body—skin cancer	0.0104	0.0399	CbGeAlD
Amobarbital—Shock—Imiquimod—skin cancer	0.0103	0.0139	CcSEcCtD
Amobarbital—CHRFAM7A—female reproductive system—skin cancer	0.0101	0.0386	CbGeAlD
Amobarbital—Body temperature increased—Vemurafenib—skin cancer	0.00971	0.0131	CcSEcCtD
Amobarbital—Somnolence—Imiquimod—skin cancer	0.00931	0.0126	CcSEcCtD
Amobarbital—GRIA2—head—skin cancer	0.00923	0.0354	CbGeAlD
Amobarbital—Hypersensitivity—Vemurafenib—skin cancer	0.00905	0.0122	CcSEcCtD
Amobarbital—GABRA6—head—skin cancer	0.00892	0.0342	CbGeAlD
Amobarbital—Hallucination—Temozolomide—skin cancer	0.00879	0.0119	CcSEcCtD
Amobarbital—GABRA5—head—skin cancer	0.00866	0.0332	CbGeAlD
Amobarbital—Feeling abnormal—Imiquimod—skin cancer	0.00863	0.0117	CcSEcCtD
Amobarbital—CHRFAM7A—head—skin cancer	0.00841	0.0323	CbGeAlD
Amobarbital—GRIK2—head—skin cancer	0.00834	0.032	CbGeAlD
Amobarbital—Body temperature increased—Imiquimod—skin cancer	0.00828	0.0112	CcSEcCtD
Amobarbital—CHRNA7—female reproductive system—skin cancer	0.00813	0.0312	CbGeAlD
Amobarbital—Dizziness—Vemurafenib—skin cancer	0.00812	0.011	CcSEcCtD
Amobarbital—GABRA3—head—skin cancer	0.00806	0.0309	CbGeAlD
Amobarbital—Ataxia—Docetaxel—skin cancer	0.00799	0.0108	CcSEcCtD
Amobarbital—GABRA4—head—skin cancer	0.00785	0.0301	CbGeAlD
Amobarbital—Vomiting—Vemurafenib—skin cancer	0.00781	0.0106	CcSEcCtD
Amobarbital—Rash—Vemurafenib—skin cancer	0.00775	0.0105	CcSEcCtD
Amobarbital—Dermatitis—Vemurafenib—skin cancer	0.00774	0.0105	CcSEcCtD
Amobarbital—Hypersensitivity—Imiquimod—skin cancer	0.00772	0.0104	CcSEcCtD
Amobarbital—Headache—Vemurafenib—skin cancer	0.0077	0.0104	CcSEcCtD
Amobarbital—Confusional state—Bleomycin—skin cancer	0.00751	0.0102	CcSEcCtD
Amobarbital—Nausea—Vemurafenib—skin cancer	0.0073	0.00987	CcSEcCtD
Amobarbital—Agitation—Temozolomide—skin cancer	0.00707	0.00956	CcSEcCtD
Amobarbital—Angioedema—Temozolomide—skin cancer	0.00703	0.00951	CcSEcCtD
Amobarbital—Hypotension—Bleomycin—skin cancer	0.00696	0.00941	CcSEcCtD
Amobarbital—Dizziness—Imiquimod—skin cancer	0.00693	0.00937	CcSEcCtD
Amobarbital—CHRNA7—head—skin cancer	0.0068	0.0261	CbGeAlD
Amobarbital—CHRNA4—head—skin cancer	0.0067	0.0257	CbGeAlD
Amobarbital—Vomiting—Imiquimod—skin cancer	0.00666	0.00901	CcSEcCtD
Amobarbital—Rash—Imiquimod—skin cancer	0.00661	0.00894	CcSEcCtD
Amobarbital—Dermatitis—Imiquimod—skin cancer	0.0066	0.00893	CcSEcCtD
Amobarbital—Headache—Imiquimod—skin cancer	0.00656	0.00888	CcSEcCtD
Amobarbital—Anxiety—Temozolomide—skin cancer	0.00653	0.00883	CcSEcCtD
Amobarbital—Confusional state—Temozolomide—skin cancer	0.00633	0.00856	CcSEcCtD
Amobarbital—Nausea—Imiquimod—skin cancer	0.00622	0.00842	CcSEcCtD
Amobarbital—Feeling abnormal—Bleomycin—skin cancer	0.00613	0.0083	CcSEcCtD
Amobarbital—GABRA2—head—skin cancer	0.006	0.023	CbGeAlD
Amobarbital—Body temperature increased—Bleomycin—skin cancer	0.00588	0.00796	CcSEcCtD
Amobarbital—Confusional state—Fluorouracil—skin cancer	0.00583	0.00789	CcSEcCtD
Amobarbital—GABRA1—head—skin cancer	0.0058	0.0222	CbGeAlD
Amobarbital—Feeling abnormal—Dactinomycin—skin cancer	0.00572	0.00774	CcSEcCtD
Amobarbital—Somnolence—Temozolomide—skin cancer	0.00558	0.00755	CcSEcCtD
Amobarbital—Body temperature increased—Dactinomycin—skin cancer	0.00549	0.00742	CcSEcCtD
Amobarbital—Hypersensitivity—Bleomycin—skin cancer	0.00548	0.00742	CcSEcCtD
Amobarbital—Hypotension—Fluorouracil—skin cancer	0.00541	0.00731	CcSEcCtD
Amobarbital—Constipation—Temozolomide—skin cancer	0.00537	0.00726	CcSEcCtD
Amobarbital—Feeling abnormal—Temozolomide—skin cancer	0.00517	0.007	CcSEcCtD
Amobarbital—Somnolence—Fluorouracil—skin cancer	0.00514	0.00696	CcSEcCtD
Amobarbital—Hypersensitivity—Dactinomycin—skin cancer	0.00511	0.00692	CcSEcCtD
Amobarbital—Body temperature increased—Temozolomide—skin cancer	0.00496	0.00671	CcSEcCtD
Amobarbital—Feeling abnormal—Fluorouracil—skin cancer	0.00477	0.00645	CcSEcCtD
Amobarbital—Vomiting—Bleomycin—skin cancer	0.00473	0.0064	CcSEcCtD
Amobarbital—Rash—Bleomycin—skin cancer	0.00469	0.00635	CcSEcCtD
Amobarbital—Dermatitis—Bleomycin—skin cancer	0.00469	0.00634	CcSEcCtD
Amobarbital—Hypersensitivity—Temozolomide—skin cancer	0.00463	0.00626	CcSEcCtD
Amobarbital—Syncope—Docetaxel—skin cancer	0.00459	0.00621	CcSEcCtD
Amobarbital—Body temperature increased—Fluorouracil—skin cancer	0.00457	0.00619	CcSEcCtD
Amobarbital—Loss of consciousness—Docetaxel—skin cancer	0.0045	0.00608	CcSEcCtD
Amobarbital—Nausea—Bleomycin—skin cancer	0.00442	0.00598	CcSEcCtD
Amobarbital—Vomiting—Dactinomycin—skin cancer	0.00441	0.00597	CcSEcCtD
Amobarbital—Rash—Dactinomycin—skin cancer	0.00438	0.00592	CcSEcCtD
Amobarbital—Hypersensitivity—Fluorouracil—skin cancer	0.00426	0.00577	CcSEcCtD
Amobarbital—Confusional state—Docetaxel—skin cancer	0.00421	0.0057	CcSEcCtD
Amobarbital—GABRA2—lymph node—skin cancer	0.0042	0.0161	CbGeAlD
Amobarbital—Dizziness—Temozolomide—skin cancer	0.00415	0.00562	CcSEcCtD
Amobarbital—Nausea—Dactinomycin—skin cancer	0.00412	0.00558	CcSEcCtD
Amobarbital—Shock—Docetaxel—skin cancer	0.00411	0.00556	CcSEcCtD
Amobarbital—Vomiting—Temozolomide—skin cancer	0.00399	0.0054	CcSEcCtD
Amobarbital—Rash—Temozolomide—skin cancer	0.00396	0.00536	CcSEcCtD
Amobarbital—Dermatitis—Temozolomide—skin cancer	0.00396	0.00535	CcSEcCtD
Amobarbital—Headache—Temozolomide—skin cancer	0.00393	0.00532	CcSEcCtD
Amobarbital—Hypotension—Docetaxel—skin cancer	0.0039	0.00528	CcSEcCtD
Amobarbital—Dizziness—Fluorouracil—skin cancer	0.00383	0.00518	CcSEcCtD
Amobarbital—Nausea—Temozolomide—skin cancer	0.00373	0.00505	CcSEcCtD
Amobarbital—Somnolence—Docetaxel—skin cancer	0.00371	0.00502	CcSEcCtD
Amobarbital—Vomiting—Fluorouracil—skin cancer	0.00368	0.00498	CcSEcCtD
Amobarbital—Rash—Fluorouracil—skin cancer	0.00365	0.00493	CcSEcCtD
Amobarbital—Dermatitis—Fluorouracil—skin cancer	0.00364	0.00493	CcSEcCtD
Amobarbital—Headache—Fluorouracil—skin cancer	0.00362	0.0049	CcSEcCtD
Amobarbital—Constipation—Docetaxel—skin cancer	0.00357	0.00483	CcSEcCtD
Amobarbital—Feeling abnormal—Docetaxel—skin cancer	0.00344	0.00465	CcSEcCtD
Amobarbital—Nausea—Fluorouracil—skin cancer	0.00344	0.00465	CcSEcCtD
Amobarbital—Body temperature increased—Docetaxel—skin cancer	0.0033	0.00447	CcSEcCtD
Amobarbital—Hypersensitivity—Docetaxel—skin cancer	0.00308	0.00416	CcSEcCtD
Amobarbital—Dizziness—Docetaxel—skin cancer	0.00276	0.00374	CcSEcCtD
Amobarbital—Vomiting—Docetaxel—skin cancer	0.00265	0.00359	CcSEcCtD
Amobarbital—Rash—Docetaxel—skin cancer	0.00263	0.00356	CcSEcCtD
Amobarbital—Dermatitis—Docetaxel—skin cancer	0.00263	0.00356	CcSEcCtD
Amobarbital—Headache—Docetaxel—skin cancer	0.00262	0.00354	CcSEcCtD
Amobarbital—Nausea—Docetaxel—skin cancer	0.00248	0.00336	CcSEcCtD
